Use of a Commercially Available Automated Insulin Delivery System for the Management of Type 1 Diabetes in Pregnancy.
Nasim C Sobhani, Christina S Han, Minhazur R Sarker, Sohum Shah, Gladys A Ramos
Author Information
- Nasim C Sobhani: Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, & Reproductive Sciences, University of California, San Francisco, San Francisco, CA, USA. ORCID
- Christina S Han: Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology, University of California, Los Angeles, Los Angeles, CA, USA.
- Minhazur R Sarker: Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, & Reproductive Sciences, University of California, San Diego, La Jolla, CA, USA. ORCID
- Sohum Shah: Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology, University of California, Los Angeles, Los Angeles, CA, USA.
- Gladys A Ramos: Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, & Reproductive Sciences, University of California, San Diego, La Jolla, CA, USA.
No abstract text available.
- Lancet Diabetes Endocrinol. 2021 Mar;9(3):153-164
[PMID: 33516295]
- Diabetes Care. 2024 Jan 1;47(Suppl 1):S126-S144
[PMID: 38078575]
- Diabetes Technol Ther. 2021 Oct;23(10):710-714
[PMID: 33945304]
- Am J Obstet Gynecol. 2024 Oct;231(4):467.e1-467.e8
[PMID: 38242337]
- Diabetes Care. 2009 Nov;32(11):2005-9
[PMID: 19675195]
